{"id":881550,"date":"2025-09-03T12:28:36","date_gmt":"2025-09-03T16:28:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/"},"modified":"2025-09-03T12:28:36","modified_gmt":"2025-09-03T16:28:36","slug":"immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/","title":{"rendered":"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d<\/b><\/p>\n<p class=\"bwalignc\"><b><i>An Evolution in Name, Structure, and Strategy Reflecting the Company\u2019s AI-Driven Platform and Bio-Native Discovery Vision<\/i><\/b><\/p>\n<p>AUSTIN, Texas&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (\u201cIPA\u201d or the \u201cCompany\u201d), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announced a unification under a single corporate brand, <strong>MindWalk<\/strong>, and a change of its Nasdaq ticker symbol to <strong>HYFT<\/strong>. The new identity conveys the Company\u2019s evolution into a <strong>Bio-Native AI<\/strong> platform business built at the intersection of AI, multi-omics data, and advanced laboratory research.<\/p>\n<p>\n\u201cToday is an evolutionary step forward,\u201d<b \/>said Dr. Jennifer Bath, President and Chief Executive Officer of MindWalk<b>.<\/b> \u201cInspired by Darwin\u2019s thinking path, MindWalk is about seeing what others can\u2019t\u2014patterns hidden in biology that point to better medicines. Our role is to convert that insight into impact, uniting science, computation, and responsible experimentation to change the pace of care.\u201d<\/p>\n<p><b>MindWalk: A New Era in Bio-Native AI-Powered Discovery<\/b><\/p>\n<p>\nInspired by Charles Darwin\u2019s daily walks along his \u201cthinking path\u201d \u2014 where he questioned convention and advanced new theories \u2014 MindWalk carries that spirit forward. It represents a modern extension of that philosophy: a transformative, pattern-seeking journey through the complexity of biology, powered by the combined strengths of AI, data and advanced lab research.<\/p>\n<p>\nNow operating as a Bio-Native AI company, MindWalk reimagines discovery by intelligently integrating data across formats and disciplines\u2014turning information into dynamic biological meaning. By making biological diversity computable, MindWalk unifies this data into a single, structured system that accelerates discovery with depth and direction.<\/p>\n<p>\nAt the core of this transformation is the Company\u2019s LensAI\u2122 platform powered by HYFT<sup>\u00ae<\/sup><strong \/>technology, built to redefine how biologics are discovered and developed. Drug discovery, unified\u2014<i>from idea to impact<\/i>. This brand evolution is also a business transformation. MindWalk is expanding beyond specialized wet-lab services to commercialize an intelligence-platform model<b>\u2014<\/b>amplifying discovery, enabling recurring SaaS offerings, creating generative asset opportunities, and supporting scalable partnerships across the pharmaceutical ecosystem.<\/p>\n<p>\nKey Business Highlights:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nUnified Brand Identity: ImmunoPrecise Antibodies (IPA) together with its subsidiaries BioStrand and Talem are now unified as MindWalk, a single brand under the umbrella of MindWalk Holdings Corp.<\/p>\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\nBusiness Model Shift: Transitioning from standalone wet-lab services to an integrated, scalable platform company model \u2014 launching DaaS, SaaS offerings, enhancing asset generation, and enabling large-scale partnerships<\/p>\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\nNew Nasdaq Ticker: \u201cHYFT\u201d \u2014 replacing \u201cIPA\u201d to reflect the foundational role of HYFT<sup>\u00ae<\/sup> technology in the company\u2019s AI stack<\/p>\n<\/li>\n<\/ul>\n<p>\n\u201cMindWalk is the first to make biological diversity truly computable \u2014 integrating multi-modal data into a structured system that drives insight with clarity, speed, and depth,\u201d added Dr. Bath.<\/p>\n<p>\nFor more information visit: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.mindwalkai.com%2F&amp;esheet=54317938&amp;newsitemid=20250903938726&amp;lan=en-US&amp;anchor=mindwalkAI.com&amp;index=1&amp;md5=17458e08e5636d8538d7ee084f2f06cc\">mindwalkAI.com<\/a><\/p>\n<p><b>About MindWalk<\/b><\/p>\n<p>\nMindWalk is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT<sup>\u00ae<\/sup> technology and the LensAI\u2122 platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, <i>de novo <\/i>molecular design, <i>in silico<\/i> vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nThis press release contains forward-looking statements within the meaning of applicable United States and Canadian securities laws. Forward-looking statements are often identified by words such as \u201cexpects,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201canticipates,\u201d \u201cbelieves,\u201d \u201cpotential,\u201d or similar expressions, or by statements that certain actions, events, or results \u201cmay,\u201d \u201cwill,\u201d \u201ccould,\u201d or \u201cmight\u201d occur or be achieved. These include, but are not limited to, statements regarding the Company\u2019s name change and ticker symbol transition to \u201cHYFT,\u201d the anticipated benefits of rebranding under the MindWalk AI identity, projected scalability and adoption of the HYFT<sup>\u00ae<\/sup> technology and LenAI\u2122 platform, and the Company\u2019s strategic shift toward a unified, AI-native discovery model.<\/p>\n<p>\nForward-looking statements are based on management\u2019s current expectations, assumptions, and projections about future events and Company performance. Actual results could differ materially from those expressed or implied due to factors beyond the Company\u2019s control, including: operational challenges in executing the rebrand and technology consolidation; risks associated with platform scalability and AI integration; scientific or technical validation hurdles; evolving market adoption dynamics in the SaaS and biologics R&amp;D sectors; economic, geopolitical, or regulatory shifts; and customer or partner response to the new corporate structure.<\/p>\n<p>\nForward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied herein. Additional information about these and other risks and uncertainties is set out in the Company\u2019s Annual Report on Form 20-F, as amended, for the fiscal year ended April 30, 2025, available on the Company\u2019s SEDAR+ profile at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sedarplus.ca%2F%3Futm_source%3Dchatgpt.com&amp;esheet=54317938&amp;newsitemid=20250903938726&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=2&amp;md5=672c2aea5233d3b907265fcfde61edf7\">www.sedarplus.ca<\/a> and EDGAR profile at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sec.gov%2Fedgar%3Futm_source%3Dchatgpt.com&amp;esheet=54317938&amp;newsitemid=20250903938726&amp;lan=en-US&amp;anchor=www.sec.gov%2Fedgar&amp;index=3&amp;md5=37ecbbce040e43f586a890e5a5498f9e\">www.sec.gov\/edgar<\/a>. If any of these risks materialize, the Company\u2019s actual results, performance, or achievements could vary significantly from those currently anticipated.<\/p>\n<p>\nReaders are cautioned not to place undue reliance on forward-looking statements. Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statements to reflect new information, future events, or otherwise.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250903938726r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250903938726\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250903938726\/en\/<\/a><\/span><\/p>\n<p><b>Investor Contact<br \/>\n<\/b><br \/>Louie Toma, CPA, CFA<br \/>\n<br \/>Managing Director, CoreIR<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investors@ipatherapeutics.com\">investors@ipatherapeutics.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Texas<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Technology Infectious Diseases Health Technology Artificial Intelligence Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250903938726\/en\/1747961\/3\/IPA_Logo_01-03-2023.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d An Evolution in Name, Structure, and Strategy Reflecting the Company\u2019s AI-Driven Platform and Bio-Native Discovery Vision AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211; ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (\u201cIPA\u201d or the \u201cCompany\u201d), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announced a unification under a single corporate brand, MindWalk, and a change of its Nasdaq ticker symbol to HYFT. The new identity conveys the Company\u2019s evolution into a Bio-Native AI platform business built at the intersection of AI, multi-omics data, and advanced laboratory research. \u201cToday is an evolutionary step forward,\u201dsaid Dr. Jennifer Bath, President and Chief Executive Officer of MindWalk. \u201cInspired by Darwin\u2019s thinking path, MindWalk is about seeing what others can\u2019t\u2014patterns &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-881550","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d An Evolution in Name, Structure, and Strategy Reflecting the Company\u2019s AI-Driven Platform and Bio-Native Discovery Vision AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211; ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (\u201cIPA\u201d or the \u201cCompany\u201d), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announced a unification under a single corporate brand, MindWalk, and a change of its Nasdaq ticker symbol to HYFT. The new identity conveys the Company\u2019s evolution into a Bio-Native AI platform business built at the intersection of AI, multi-omics data, and advanced laboratory research. \u201cToday is an evolutionary step forward,\u201dsaid Dr. Jennifer Bath, President and Chief Executive Officer of MindWalk. \u201cInspired by Darwin\u2019s thinking path, MindWalk is about seeing what others can\u2019t\u2014patterns &hellip; Continue reading &quot;ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-03T16:28:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250903938726r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d\",\"datePublished\":\"2025-09-03T16:28:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\\\/\"},\"wordCount\":898,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250903938726r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\\\/\",\"name\":\"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250903938726r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-09-03T16:28:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250903938726r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250903938726r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/","og_locale":"en_US","og_type":"article","og_title":"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d - Market Newsdesk","og_description":"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d An Evolution in Name, Structure, and Strategy Reflecting the Company\u2019s AI-Driven Platform and Bio-Native Discovery Vision AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211; ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (\u201cIPA\u201d or the \u201cCompany\u201d), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announced a unification under a single corporate brand, MindWalk, and a change of its Nasdaq ticker symbol to HYFT. The new identity conveys the Company\u2019s evolution into a Bio-Native AI platform business built at the intersection of AI, multi-omics data, and advanced laboratory research. \u201cToday is an evolutionary step forward,\u201dsaid Dr. Jennifer Bath, President and Chief Executive Officer of MindWalk. \u201cInspired by Darwin\u2019s thinking path, MindWalk is about seeing what others can\u2019t\u2014patterns &hellip; Continue reading \"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-03T16:28:36+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250903938726r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d","datePublished":"2025-09-03T16:28:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/"},"wordCount":898,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250903938726r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/","name":"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250903938726r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-09-03T16:28:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250903938726r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250903938726r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunoprecise-rebrands-as-mindwalk-announces-nasdaq-ticker-change-to-hyft\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to \u201cHYFT\u201d"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/881550","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=881550"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/881550\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=881550"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=881550"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=881550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}